@article{25c8e09a7d2942d68d08050c4062c1c9,
title = "A micrococcal nuclease homologue in RNAi effector complexes",
abstract = "RNA interference (RNAi) regulates gene expression by the cleavage of messenger RNA, by mRNA degradation and by preventing protein synthesis. These effects are mediated by a ribonucleo-protein complex known as RISC (RNA-induced silencing complex. We have previously identified four Drosophila components (short interfering RNAs, Argonaute 2 (ref. 2), VIG and FXR of a RISC enzyme that degrades specific mRNAs in response to a double-stranded-RNA trigger. Here we show that Tudor-SN (tudor staphylococcal nuclease) - a protein containing five staphylococcal/micrococcal nuclease domains and a tudor domain - is a component of the RISC enzyme in Caenorhabditis elegans, Drosophila and mammals. Although Tudor-SN contains non-canonical active-site sequences, we show that purified Tudor-SN exhibits nuclease activity similar to that of other staphylococcal nucleases. Notably, both purified Tudor-SN and RISC are inhibited by a specific competitive inhibitor of micrococcal nuclease. Tudor-SN is the first RISC subunit to be identified that contains a recognizable nuclease domain, and could therefore contribute to the RNA degradation observed in RNAi.",
keywords = "Animals, Binding Sites, Caenorhabditis elegans/enzymology, Drosophila melanogaster/enzymology, Macromolecular Substances, Micrococcal Nuclease/chemistry, Protein Structure, Tertiary, RNA Interference, RNA Processing, Post-Transcriptional, RNA-Induced Silencing Complex/chemistry",
author = "Caudy, {Amy A.} and Ketting, {Ren{\'e} F.} and Hammond, {Scott M.} and Denli, {Ahmet M.} and Bathoorn, {Anja M.P.} and Tops, {Bastiaan B.J.} and Silva, {Jose M.} and Myers, {Mike M.} and Hannon, {Gregory J.} and Plasterk, {Ronald H.A.}",
note = "Funding Information: Acknowledgements We thank A. Mildvan, M. Tijsterman and T. Sijen for discussions. We thank T. Keenan for an anti-p100 antibody, T. Hobman for GERP (EIF2C2/hAgo2) antibody, H. Siomi for a FXR monoclonal antibody, and F. Slack for the lacZ–lin-41 reporter. A.A.C. is a George A. and Marjorie H. Anderson Fellow of the Watson School of Biological Sciences, and a Howard Hughes Medical Institute Predoctoral Fellow. A.M.D. is a David Koch Fellow of the Watson School of Biological Sciences. J.M.S. is supported by a postdoctoral fellowship from the US Army Prostate Cancer Research programme. G.J.H. is a Rita Allen Foundation Scholar and is supported by an Innovator Award from the US Army Breast Cancer Research programme. This work was also supported by a grant from the National Institutes of Health (G.J.H.) and by a VENI fellowship from the Netherlands Organization for Scientific Research (RFK).",
year = "2003",
month = sep,
day = "25",
doi = "10.1038/nature01956",
language = "English",
volume = "425",
pages = "411--414",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Research",
number = "6956",
}